News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
705,027 Results
Type
Article (40025)
Company Profile (250)
Press Release (664751)
Multimedia
Podcasts (60)
Webinars (14)
Section
Business (204288)
Career Advice (2011)
Deals (35453)
Drug Delivery (96)
Drug Development (81140)
Employer Resources (172)
FDA (16252)
Job Trends (14889)
News (345517)
Policy (32607)
Tag
Academia (2556)
Accelerated approval (10)
Adcomms (22)
Allergies (95)
Alliances (49570)
ALS (109)
Alzheimer's disease (1446)
Antibody-drug conjugate (ADC) (151)
Approvals (16248)
Artificial intelligence (311)
Autoimmune disease (28)
Automation (19)
Bankruptcy (361)
Best Places to Work (11636)
BIOSECURE Act (19)
Biosimilars (123)
Biotechnology (175)
Bladder cancer (94)
Brain cancer (34)
Breast cancer (368)
Cancer (2881)
Cardiovascular disease (213)
Career advice (1682)
Career pathing (30)
CAR-T (185)
CDC (30)
Cell therapy (500)
Cervical cancer (22)
Clinical research (66876)
Collaboration (1018)
Company closure (3)
Compensation (692)
Complete response letters (23)
COVID-19 (2625)
CRISPR (57)
C-suite (330)
Cystic fibrosis (113)
Data (3014)
Decentralized trials (2)
Denatured (20)
Depression (61)
Diabetes (346)
Diagnostics (6426)
Digital health (23)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (138)
Drug pricing (122)
Drug shortages (28)
Duchenne muscular dystrophy (130)
Earnings (87474)
Editorial (40)
Employer branding (21)
Employer resources (148)
Events (113763)
Executive appointments (847)
FDA (17918)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (933)
Gene editing (131)
Generative AI (22)
Gene therapy (375)
GLP-1 (783)
Government (4504)
Grass and pollen (4)
Guidances (182)
Healthcare (18841)
HIV (40)
Huntington's disease (30)
IgA nephropathy (39)
Immunology and inflammation (148)
Immuno-oncology (9)
Indications (39)
Infectious disease (2797)
Inflammatory bowel disease (149)
Inflation Reduction Act (10)
Influenza (62)
Intellectual property (120)
Interviews (312)
IPO (16591)
IRA (45)
Job creations (3637)
Job search strategy (1424)
Kidney cancer (13)
Labor market (53)
Layoffs (495)
Leadership (19)
Legal (7929)
Liver cancer (79)
Longevity (11)
Lung cancer (402)
Lymphoma (209)
Machine learning (11)
Management (58)
Manufacturing (390)
MASH (91)
Medical device (13465)
Medtech (13470)
Mergers & acquisitions (19584)
Metabolic disorders (850)
Multiple sclerosis (97)
NASH (16)
Neurodegenerative disease (116)
Neuropsychiatric disorders (32)
Neuroscience (2126)
NextGen: Class of 2025 (6517)
Non-profit (4488)
Now hiring (48)
Obesity (428)
Opinion (217)
Ovarian cancer (101)
Pain (107)
Pancreatic cancer (122)
Parkinson's disease (186)
Partnered (22)
Patents (302)
Patient recruitment (167)
Peanut (50)
People (57698)
Pharmaceutical (63)
Pharmacy benefit managers (21)
Phase I (20836)
Phase II (29457)
Phase III (21922)
Pipeline (1644)
Policy (202)
Postmarket research (2563)
Preclinical (8873)
Press Release (64)
Prostate cancer (140)
Psychedelics (37)
Radiopharmaceuticals (253)
Rare diseases (460)
Real estate (5917)
Recruiting (66)
Regulatory (22644)
Reports (50)
Research institute (2326)
Resumes & cover letters (350)
Rett syndrome (9)
RNA editing (8)
RSV (49)
Schizophrenia (86)
Series A (157)
Series B (108)
Service/supplier (11)
Sickle cell disease (60)
Special edition (18)
Spinal muscular atrophy (148)
Sponsored (32)
Startups (3588)
State (2)
Stomach cancer (14)
Supply chain (76)
Tariffs (58)
The Weekly (38)
Vaccines (779)
Venture capital (54)
Weight loss (257)
Women's health (47)
Worklife (16)
Date
Today (88)
Last 7 days (365)
Last 30 days (1809)
Last 365 days (31174)
2025 (16912)
2024 (35228)
2023 (40076)
2022 (51173)
2021 (55710)
2020 (54083)
2019 (46538)
2018 (35018)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26346)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (720)
Alabama (61)
Alaska (7)
Arizona (244)
Arkansas (13)
Asia (38221)
Australia (6234)
California (7455)
Canada (2366)
China (672)
Colorado (320)
Connecticut (325)
Delaware (192)
Europe (82124)
Florida (1122)
Georgia (248)
Hawaii (1)
Idaho (59)
Illinois (641)
India (27)
Indiana (361)
Iowa (17)
Japan (229)
Kansas (109)
Kentucky (29)
Louisiana (14)
Maine (64)
Maryland (1032)
Massachusetts (5551)
Michigan (246)
Minnesota (453)
Mississippi (3)
Missouri (90)
Montana (28)
Nebraska (25)
Nevada (81)
New Hampshire (66)
New Jersey (2084)
New Mexico (28)
New York (2091)
North Carolina (1082)
North Dakota (8)
Northern California (3283)
Ohio (237)
Oklahoma (16)
Oregon (34)
Pennsylvania (1616)
Puerto Rico (17)
Rhode Island (36)
South America (1098)
South Carolina (34)
South Dakota (1)
Southern California (2792)
Tennessee (126)
Texas (1128)
United States (27660)
Utah (220)
Virginia (187)
Washington D.C. (72)
Washington State (634)
West Virginia (4)
Wisconsin (66)
705,027 Results for "engene inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
FDA Grants RMAT Designation for enGene’s Detalimogene, Enabling Potential for Expedited Review in High-Risk, Non-Muscle Invasive Bladder Cancer
June 25, 2025
·
7 min read
Press Releases
enGene to Present at the Jefferies Global Healthcare Conference
May 29, 2025
·
1 min read
Press Releases
enGene Announces the Resignation of its Chief Medical Officer
June 4, 2025
·
3 min read
Press Releases
enGene Names Amy Pott as Chief Global Commercialization Officer
May 28, 2025
·
6 min read
Press Releases
enGene Reports Second Quarter 2025 Financial Results and Provides Business Update
June 12, 2025
·
11 min read
Press Releases
enGene to Participate in Upcoming May 2025 Investor Conferences
April 29, 2025
·
1 min read
Press Releases
enGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) to four newly-hired employees
June 17, 2025
·
2 min read
Press Releases
enGene to Present at the Stifel 2025 Virtual Targeted Oncology Forum
April 1, 2025
·
1 min read
Press Releases
enGene to Participate in the Leerink Partners Global Healthcare Conference
March 4, 2025
·
1 min read
Press Releases
EnGeneIC launches groundbreaking new Australian trial for innovative cancer therapy, with international trial site in Singapore to follow
May 13, 2025
·
3 min read
1 of 70,503
Next
